Reckon Health Care Holdings Ltd (AU:GGR)
ASX:GGR
Want to see AU:GGR full AI Analyst Report?
Top Page
Reckon Health Care Holdings Ltd
(Sydney:GGR)
Select Model
Select Model
Rating:46Neutral
Price Target:
AU$0.25
▲(22.50% Upside)
Action:ReiteratedDate:03/12/26
The score is primarily held down by very weak financial performance (losses, minimal revenue, and ongoing cash burn). Technical indicators provide some near-term support, but valuation remains challenged due to negative earnings and no provided dividend yield.
Positive Factors
Modest leverage
Lower leverage (debt-to-equity near 0.33 in 2025) reduces near-term solvency pressure and interest burden. That structural flexibility gives management time to execute restructuring, seek financing, or realign operations without immediate covenant stress, supporting survival through recovery.
Negative Factors
Persistent net losses and near-zero revenue
Ongoing net losses combined with minimal or zero revenue in 2024–2025 show the core business lacks scale and market traction. Without material revenue, the company cannot demonstrate unit economics or cover fixed costs, making a durable path to profitability unclear and financing-dependent.
Read all positive and negative factors
Positive Factors
Negative Factors
Modest leverage
Lower leverage (debt-to-equity near 0.33 in 2025) reduces near-term solvency pressure and interest burden. That structural flexibility gives management time to execute restructuring, seek financing, or realign operations without immediate covenant stress, supporting survival through recovery.
Read all positive factors
Reckon Health Care Holdings Ltd (GGR) vs. iShares MSCI Australia ETF (EWA)
Market Cap
N/A
Dividend YieldN/A
Average Volume (3M)299.00K
Price to Earnings (P/E)―
Beta (1Y)0.76
Revenue GrowthN/A
EPS GrowthN/A
CountryAU
Employees1
SectorBasic Materials
Sector Strength58
IndustryOther Precious Metals
Share Statistics
EPS (TTM)N/A
Shares Outstanding140,024,220
10 Day Avg. Volume126,568
30 Day Avg. Volume298,997
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)14.06
Price to Sales (P/S)0.00
P/FCF Ratio-30.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Reckon Health Care Holdings Ltd Business Overview & Revenue Model
Company Description
Golden Globe Resources Ltd, a minerals exploration company, focuses on identifying and developing of copper and gold assets in Australia. Its propertes holds 100% interest in the Dooloo Creek Project comprises two granted exploration permits cover...
Reckon Health Care Holdings Ltd Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
38
Negative
Cash Flow
20
Very Negative
| Breakdown | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 0.00 | 7.64K | 0.00 | 7.18K |
| Gross Profit | 0.00 | 0.00 | 7.64K | 0.00 | 7.18K |
| EBITDA | 0.00 | 0.00 | -1.20M | -1.20M | -1.40M |
| Net Income | -1.81M | -1.16M | -1.39M | -1.49M | -1.44M |
Balance Sheet | |||||
| Total Assets | 2.55M | 2.35M | 2.96M | 3.69M | 3.63M |
| Cash, Cash Equivalents and Short-Term Investments | 261.65K | 1.36K | 189.50K | 1.07M | 1.11M |
| Total Debt | 389.86K | 253.00K | 0.00 | 37.50K | 106.50K |
| Total Liabilities | 1.38M | 678.14K | 205.41K | 119.17K | 238.97K |
| Stockholders Equity | 1.18M | 1.67M | 2.75M | 3.57M | 3.39M |
Cash Flow | |||||
| Free Cash Flow | -546.49K | -479.95K | -1.28M | -1.71M | -2.48M |
| Operating Cash Flow | -482.67K | -373.72K | -1.08M | -1.16M | -1.46M |
| Investing Cash Flow | -47.70K | 110.08K | -329.26K | -557.37K | -1.49M |
| Financing Cash Flow | 790.65K | 75.50K | 530.73K | 1.68M | 3.61M |
Reckon Health Care Holdings Ltd Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
* Basic Materials Sector Average
Performance Comparison
Reckon Health Care Holdings Ltd Corporate Events
Golden Globe Resources Starts Drilling at Neila Creek as Dual Exploration Push Builds
Mar 3, 2026
Golden Globe Resources has begun a Phase 1 diamond drilling program at its Neila Creek project in central New South Wales, targeting interpreted gold and copper mineralisation in an early-stage tenement within the Lachlan Fold Belt. The three-hole...
Golden Globe Resources Cancels 750,000 Restricted Options by Agreement
Mar 2, 2026
Golden Globe Resources has announced the cessation of 750,000 restricted options expiring on 31 October 2027, following a cancellation agreed between the company and the option holders. The move slightly reduces the company’s potential futur...
Golden Globe Resources Amends Quarterly Report as Drilling Ramps Up Post-IPO
Feb 9, 2026
Golden Globe Resources has issued an amended quarterly activities and cash flow report for the period to 31 December 2025, updating disclosures on tenement changes and exploration expenditure to align with ASX listing requirements. The clarificati...
Golden Globe Resources Hits ASX With Fully Funded Drilling Push at Dooloo Creek
Jan 22, 2026
Golden Globe Resources reported a milestone December quarter marked by the successful completion of its oversubscribed Initial Public Offering, raising A$8.5 million and securing admission to the ASX, which transitions the group into a fully funde...
Golden Globe Resources Tightens Governance with New Joint Company Secretary and Office Move
Jan 18, 2026
Golden Globe Resources has appointed Ms Anshu Raghuvanshi of Acclime Corporate Services Australia as Joint Company Secretary, working alongside existing secretary Anthony Rule, with Raghuvanshi taking responsibility for the company’s communi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.